{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:17:32Z","timestamp":1778901452603,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec018\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>To evaluate the impact of monitor units (MUs) optimization on volumetric modulated arc therapy (VMAT) plan for nasopharyngeal carcinoma (NPC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec019\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Twenty-one NPC patients were retrospectively analyzed. Dual-arc VMAT plan were designed using photon optimization algorithms without the monitor unit objective (MUO) tool, denoted as the base plan. Each base plan was re-optimized with the MUO tool with the Maximum MU parameter set to 30% of the base plans\u2019 total MUs and Strength parameters set to 50, 80, and 100, generating plans S<jats:sub>50<\/jats:sub>, S<jats:sub>80<\/jats:sub>, and S<jats:sub>100<\/jats:sub>. Target and organ-at-risk (OAR) dose distributions, MUs, beam delivery time, and gamma passing rates were compared between re-optimized and base plans. Statistical analysis was performed using SPSS 17.0 (paired t-tests; significance: P\u2009&lt;\u20090.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec020\">\n<jats:title>Results<\/jats:title>\n<jats:p>Plan S<jats:sub>100<\/jats:sub> reduced target PCTV2 D<jats:sub>98%<\/jats:sub> by &gt;4% (relative to the base plan) in four patients. Plan S<jats:sub>80<\/jats:sub> reduced target PGTV and PGTVnd D<jats:sub>max<\/jats:sub> and target PCTV2 D<jats:sub>98%<\/jats:sub> for &gt;3% but &lt;4% in two patients, while other target dose parameters changed by &lt;2%. Compared to the base plan, all re-optimized plans increased the brainstem D<jats:sub>max<\/jats:sub> (P\u2009&lt;\u20090.05), though the maximum increase was\u2009&lt;\u20091.5%. Plan S<jats:sub>50<\/jats:sub> reduced both parotid glands D<jats:sub>50%<\/jats:sub> and D<jats:sub>mean<\/jats:sub> (P\u2009&lt;\u20090.001), while plan S<jats:sub>80<\/jats:sub> reduced both parotids D<jats:sub>mean<\/jats:sub> and the left parotid D<jats:sub>50%<\/jats:sub> (P\u2009&lt;\u20090.001). Conversely, S<jats:sub>100<\/jats:sub> increased both parotids D<jats:sub>50%<\/jats:sub> and D<jats:sub>mean<\/jats:sub> and the spinal cord D<jats:sub>max<\/jats:sub> (P\u2009&lt;\u20090.05). Plan S<jats:sub>80<\/jats:sub> and S<jats:sub>100<\/jats:sub> increased the thyroid V<jats:sub>40<\/jats:sub> (P\u2009&lt;\u20090.05). MU reductions averaged 5.1% (S<jats:sub>50<\/jats:sub>), 21.4% (S<jats:sub>80<\/jats:sub>), and 30.9% (S<jats:sub>100<\/jats:sub>), with consistent beam delivery times (~2.5 minutes). Gamma passing rates improved sequentially from the base plan to S<jats:sub>50<\/jats:sub>, S<jats:sub>80<\/jats:sub>, and S<jats:sub>100<\/jats:sub>.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec021\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>MU optimization in NPC VMAT planning effectively reduces MUs and enhances delivery accuracy (improved gamma passing rates). While target coverage and OAR sparing were generally maintained, higher MUO strengths (e.g., S<jats:sub>100<\/jats:sub>) may necessitate careful consideration of dosimetric trade-offs. Moderate MUO settings (e.g., S<jats:sub>80<\/jats:sub>) offer a favorable balance between MU reduction and plan fidelity.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0327153","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:20:04Z","timestamp":1750875604000},"page":"e0327153","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of monitor unit optimization in volumetric modulated arc therapy planning for nasopharyngeal carcinoma"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4671-7161","authenticated-orcid":true,"given":"Huaqu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minzhi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunbei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"11","key":"pone.0327153.ref001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11604-017-0680-5","article-title":"Clinical outcomes of concurrent chemoradiotherapy with volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma","volume":"35","author":"N Imano","year":"2017","journal-title":"Jpn J Radiol"},{"issue":"3","key":"pone.0327153.ref002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.meddos.2018.09.003","article-title":"Nasopharyngeal carcinoma radiotherapy with hybrid technique","volume":"44","author":"U Akbas","year":"2019","journal-title":"Med Dosim"},{"issue":"1","key":"pone.0327153.ref003","doi-asserted-by":"crossref","DOI":"10.1186\/s41936-019-0083-5","article-title":"Recent advances in radiotherapy and its associated side effects in cancer\u2014a review","volume":"80","author":"G Mohan","year":"2019","journal-title":"JoBAZ"},{"issue":"3","key":"pone.0327153.ref004","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hed.24993","article-title":"Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis","volume":"40","author":"YH Leong","year":"2018","journal-title":"Head Neck"},{"issue":"1102","key":"pone.0327153.ref005","doi-asserted-by":"crossref","first-page":"20190209","DOI":"10.1259\/bjr.20190209","article-title":"Future of Radiotherapy in Nasopharyngeal Carcinoma","volume":"92","author":"X-S Sun","year":"2019","journal-title":"Br J Radiol"},{"issue":"7","key":"pone.0327153.ref006","article-title":"Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities","volume":"10","author":"R Guo","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"pone.0327153.ref007","first-page":"979","article-title":"Dosimetric analysis of VMAT irradiation in nasopharyngeal carcinoma: A Moroccan radio oncology center\u2019s experience","volume":"8","author":"B Amaoui","year":"2021","journal-title":"Eur J Mol Clin Med"},{"issue":"1","key":"pone.0327153.ref008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5603\/RPOR.a2021.0017","article-title":"Dosimetric impact of volumetric modulated arc therapy for nasopharyngeal cancer treatment","volume":"26","author":"C Franzese","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"pone.0327153.ref009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1118\/1.2818738","article-title":"Volumetric modulated arc therapy: IMRT in a single gantry arc","volume":"35","author":"K Otto","year":"2008","journal-title":"Med Phys"},{"key":"pone.0327153.ref010","doi-asserted-by":"crossref","first-page":"646584","DOI":"10.3389\/fonc.2021.646584","article-title":"Comparison of Dosimetric Benefits of Three Precise Radiotherapy Techniques in Nasopharyngeal Carcinoma Patients Using a Priority-Classified Plan Optimization Model","volume":"11","author":"Q Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"pone.0327153.ref011","doi-asserted-by":"crossref","first-page":"102476","DOI":"10.1016\/j.jksus.2022.102476","article-title":"Dosimetric analysis of Rapid Arc (VMAT) treatment planning in head and neck cancer for quality assurance treatment","volume":"35","author":"N Amin","year":"2023","journal-title":"J King Saud University - Sci"},{"issue":"1","key":"pone.0327153.ref012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13014-020-01602-7","article-title":"Dosimetric comparison between RapidArc and HyperArc techniques in salvage stereotactic body radiation therapy for recurrent nasopharyngeal carcinoma","volume":"15","author":"H-W Ho","year":"2020","journal-title":"Radiat Oncol"},{"issue":"1","key":"pone.0327153.ref013","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acm2.12224","article-title":"On the gEUD biological optimization objective for organs at risk in Photon Optimizer of Eclipse treatment planning system","volume":"19","author":"A Fogliata","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"4","key":"pone.0327153.ref014","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.meddos.2017.11.004","article-title":"Fine-tuning the normal tissue objective in eclipse for lung stereotactic body radiation therapy","volume":"43","author":"JP Bell","year":"2018","journal-title":"Med Dosim"},{"issue":"2","key":"pone.0327153.ref015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rpor.2018.02.001","article-title":"Assessment of the Monitor Unit Objective tool for VMAT in the Eclipse treatment planning system","volume":"23","author":"S Jim\u00e9nez-Puertas","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"pone.0327153.ref016","first-page":"3114","article-title":"Analysis of RapidArc optimization strategies using objective function values and dose-volume histograms","volume":"11","author":"M Oliver","year":"2009","journal-title":"J Appl Clin Med Phys"},{"key":"pone.0327153.ref017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmp.2017.01.016","article-title":"Assessment of monitor unit limiting strategy using volumetric modulated arc therapy for cancer of hypopharynx","volume":"35","author":"S Ahamed","year":"2017","journal-title":"Phys Med"},{"issue":"3","key":"pone.0327153.ref018","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1120\/jacmp.v14i3.4114","article-title":"Monitor unit optimization in RapidArc plans for prostate cancer","volume":"14","author":"S Clemente","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"pone.0327153.ref019","doi-asserted-by":"crossref","first-page":"18453","DOI":"10.1038\/srep18453","article-title":"Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients","volume":"5","author":"B-T Huang","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0327153.ref020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmp.2013.08.142","article-title":"Total monitor units influence on plan quality parameters in volumetric modulated arc therapy for breast case","volume":"30","author":"P Mancosu","year":"2014","journal-title":"Phys Med"},{"issue":"8","key":"pone.0327153.ref021","first-page":"10","article-title":"Research Progress of Radiotherapy for Nasopharyngeal Carcinoma","volume":"4","author":"A Zhang","year":"2022","journal-title":"Int J Front Med"},{"issue":"2","key":"pone.0327153.ref022","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"NY Lee","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"pone.0327153.ref023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","article-title":"Verordnung, Dokumentation und Kommunikation der fluenzmodulierten Photonenstrahlentherapie (IMRT) [The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)]","volume":"88","author":"N Hodapp","year":"2012","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"pone.0327153.ref024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rpor.2019.02.004","article-title":"Performance of the eclipse monitor unit objective tool utilizing volumetric modulated arc therapy for rectal cancer","volume":"24","author":"A Prado","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"issue":"4","key":"pone.0327153.ref025","doi-asserted-by":"crossref","DOI":"10.1002\/mp.12810","article-title":"Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218","volume":"45","author":"M Miften","year":"2018","journal-title":"Med Phys"},{"key":"pone.0327153.ref026","author":"International atomic energy agency, Absorbed Dose Determination in External Beam Radiotherapy, Technical Reports Series No","year":"2024"},{"issue":"1","key":"pone.0327153.ref027","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hed.25986","article-title":"The relations of dosimetric parameters with long-term outcomes and late toxicities in advanced T-stage nasopharyngeal carcinoma with IMRT","volume":"42","author":"X Gou","year":"2020","journal-title":"Head Neck"},{"key":"pone.0327153.ref028","doi-asserted-by":"crossref","first-page":"764946","DOI":"10.3389\/fonc.2021.764946","article-title":"Dosimetric comparison of helical tomotherapy, volume-modulated arc therapy, and fixed-field intensity-modulated radiation therapy in locally advanced nasopharyngeal carcinoma","volume":"11","author":"S Lu","year":"2021","journal-title":"Front Oncol"},{"key":"pone.0327153.ref029","doi-asserted-by":"crossref","first-page":"104978","DOI":"10.1016\/j.oraloncology.2020.104978","article-title":"Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center\u2019s experience","volume":"109","author":"L He","year":"2020","journal-title":"Oral Oncol"},{"key":"pone.0327153.ref030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CMAR.S145713","article-title":"Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT","volume":"10","author":"H-F Lee","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"1","key":"pone.0327153.ref031","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-020-01532-4","article-title":"Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy","volume":"15","author":"T-L Huang","year":"2020","journal-title":"Radiat Oncol"},{"issue":"2","key":"pone.0327153.ref032","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jmir.2014.11.003","article-title":"A comparative planning analysis and integral dose of volumetric modulated arc therapy, helical tomotherapy, and three-dimensional conformal craniospinal irradiation for pediatric medulloblastoma","volume":"46","author":"S Patel","year":"2015","journal-title":"J Med Imaging Radiat Sci"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:20:14Z","timestamp":1750875614000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0327153"}},"subtitle":[],"editor":[{"given":"Chung-Ta","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0327153","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}